Name: Vistagen Therapeutics, Inc. (VTGN) Balance Sheet
Creator: FinSpry

Vistagen Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Vistagen Therapeutics, Inc. (VTGN) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Current Assets
Cash and Cash Equivalents	67.13	119.17	16.64	68.14	103.11	1.36	13.10
Short-Term Investments	13.35	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	80.48	119.17	16.64	68.14	103.11	1.36	13.10
Accounts Receivable	0.00	0.00	0.80	2.75	0.04	0.00	0.30
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.59	1.51	0.50	1.09	0.93	0.81	0.02
Total Current Assets	82.08	120.67	18.00	71.00	104.12	1.58	13.63
Non-Current Assets
Property, Plant & Equipment (Net)	1.81	2.26	2.77	3.08	3.59	3.79	0.31
Other Non-Current Assets	0.45	0.73	0.50	0.10	0.05	0.00	0.00
Total Non-Current Assets	2.27	2.98	3.09	3.65	4.16	3.84	0.38
Total Assets	84.34	123.65	21.09	74.64	108.28	5.77	14.01
Current Liabilities
Accounts Payable	0.65	1.55	3.27	4.09	2.40	2.40	2.30
Short-Term Debt	0.56	0.00	0.11	0.00	0.00	0.00	0.00
Accrued Liabilities	5.45	2.24	0.80	1.26	1.56	0.00	0.00
Deferred Revenue	2.59	0.79	0.71	1.24	1.42	0.00	0.00
Other Current Liabilities	8.81	0.00	0.34	0.07	6.27	0.00	0.00
Total Current Liabilities	12.61	5.12	4.57	5.77	4.19	27.71	2.80
Non-Current Liabilities
Long-Term Debt	0.95	1.57	2.12	2.61	3.35	3.72	0.01
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	6.27	5.01	0.00
Total Non-Current Liabilities	1.34	4.24	4.44	4.16	12.11	8.73	4.14
Total Liabilities	13.95	9.37	9.01	9.93	16.30	11.50	6.94
Stockholders' Equity
Common Stock	0.03	0.03	0.01	0.01	0.18	0.00	0.00
Retained Earnings	-407.63	-356.21	-326.85	-267.60	-219.84	-201.91	-181.13
Accumulated Other Comprehensive Income	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Treasury Stock	3.97	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97
Additional Paid-in Capital	481.96	474.44	342.89	336.28	315.60	200.09	192.13
Shares Outstanding	29.00	27.03	7.31	6.88	0.00	0.00	0.00
Total Stockholders' Equity	70.39	114.29	12.08	64.72	91.97	-5.73	7.08
Total Liabilities & Equity	84.34	123.65	21.09	74.64	108.28	5.77	14.01